Drug intelligence / Profile preview

felodipine + lisinopril

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

Felodipine + lisinopril is a combination of two antihypertensive agents used to treat high blood pressure. Felodipine is a long-acting dihydropyridine calcium channel blocker that works by inhibiting the influx of calcium ions through voltage-gated L-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure[3][6][8]. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that prevents the conversion of angiotensin I to angiotensin II, resulting in vasodilation and decreased aldosterone secretion, which also lowers blood pressure[5]. This combination targets different mechanisms within the cardiovascular system for additive antihypertensive effects.

02

Targets

CaM (Calmodulin)ACE (Angiotensin Converting Enzyme)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)MR (Mineralocorticoid receptor)PDE1A (Phosphodiesterase 1A)CaV3 (Caveolin-3)

Beyond the preview

Go deeper on felodipine + lisinopril.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on felodipine + lisinopril.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call